share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股sec公告 ·  05/30 11:53
Moomoo AI 已提取核心訊息
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,350 shares of common stock on 05/30/2024, with an aggregate market value of approximately $1,031,908. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction from the issuer. There have been no other securities sold by Tatsis in the past three months prior to the notice date of the planned sale.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,350 shares of common stock on 05/30/2024, with an aggregate market value of approximately $1,031,908. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction from the issuer. There have been no other securities sold by Tatsis in the past three months prior to the notice date of the planned sale.
Vertex Pharmicals Inc.高管歐拉尼亞·塔西斯定於2024年5月30日出售2350股普通股,總市值約爲1,031,908美元。這些股票於2024年2月24日作爲限制性股票歸屬的一部分收購,這是發行人與薪酬相關的交易。在計劃出售的通知日期之前的過去三個月中,塔西斯沒有出售其他證券。
Vertex Pharmicals Inc.高管歐拉尼亞·塔西斯定於2024年5月30日出售2350股普通股,總市值約爲1,031,908美元。這些股票於2024年2月24日作爲限制性股票歸屬的一部分收購,這是發行人與薪酬相關的交易。在計劃出售的通知日期之前的過去三個月中,塔西斯沒有出售其他證券。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息